Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Aethlon Medical (AEMD) over the last 15 years, with Q1 2025 value amounting to $83864.0.

  • Aethlon Medical's Depreciation & Amortization (CF) fell 229.29% to $83864.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $339559.0, marking a year-over-year decrease of 543.03%. This contributed to the annual value of $339559.0 for FY2025, which is 543.03% down from last year.
  • According to the latest figures from Q1 2025, Aethlon Medical's Depreciation & Amortization (CF) is $83864.0, which was down 229.29% from $83808.0 recorded in Q4 2024.
  • Over the past 5 years, Aethlon Medical's Depreciation & Amortization (CF) peaked at $91473.0 during Q4 2023, and registered a low of $11164.0 during Q1 2021.
  • In the last 5 years, Aethlon Medical's Depreciation & Amortization (CF) had a median value of $79542.0 in 2023 and averaged $63197.5.
  • As far as peak fluctuations go, Aethlon Medical's Depreciation & Amortization (CF) skyrocketed by 64451.52% in 2021, and later plummeted by 2383.23% in 2022.
  • Over the past 5 years, Aethlon Medical's Depreciation & Amortization (CF) (Quarter) stood at $17673.0 in 2021, then skyrocketed by 342.06% to $78126.0 in 2022, then rose by 17.08% to $91473.0 in 2023, then decreased by 8.38% to $83808.0 in 2024, then grew by 0.07% to $83864.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $83864.0 for Q1 2025, versus $83808.0 for Q4 2024 and $85827.0 for Q3 2024.